BIOMAT Database Logo BIOMAT Database Logo

Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases. 1991

G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Department of Pediatric Hematology/Oncology-Bone Marrow Transplant Unit, Giannina Gaslini Children's Hospital, Genova, Italy.

From October 1984 to November 1987, 34 patients aged from 1 year 1 month to 7 years 7 months with resistant or relapsed neuroblastoma (NB) (group 1, 10 patients), unselected disseminated NB (group 2, 14 patients), or selected disseminated NB (group 3, 10 patients) received myeloablative therapy (MAT) followed by unpurged autologous bone marrow transplantation (ABMT) at the end of an intensive protocol, which included high-dose chemotherapy and surgery to the primary tumor. Median time from diagnosis to MAT and ABMT was 6 months (5 months from last relapse to MAT and ABMT in the relapsed patients). The MAT regimen included vincristine, fractionated total body irradiation (TBI), and melphalan. Seventeen patients were grafted in complete remission (CR), five in very good partial remission (VGPR), 10 in partial remission (PR), and two in progressive disease (PD). The acute toxic death rate was 2.9%. The overall progression-free survival was 29%. The median progression-free survival was 20 months for the 17 patients grafted in CR, 6 months for the five patients grafted in VGPR, and 12 months for the 10 patients grafted in PR.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
January 1991, Progress in clinical and biological research,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Purged autologous bone marrow transplantation in 25 cases of very poor prognosis neuroblastoma.
March 1985, Lancet (London, England),
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Chemo-radiotherapy and autologous bone marrow transplantation in poor prognosis neuroblastoma.
January 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Bone marrow transplantation for poor prognosis neuroblastoma.
January 1988, Progress in clinical and biological research,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
January 1985, Progress in clinical and biological research,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Autologous bone marrow transplantation for patients with poor-prognosis lymphoma.
August 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
December 1996, Bone marrow transplantation,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
January 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Autologous bone marrow transplantation for advanced neuroblastoma.
January 1992, Progress in clinical and biological research,
G Dini, and E Lanino, and A Garaventa, and D Rogers, and S Dallorso, and C Viscoli, and E Castagnola, and G Manno, and M Brisigotti, and C Rosanda
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.
January 1991, Leukemia & lymphoma,
Copied contents to your clipboard!